{
  "id": 10855553,
  "title": "DBV Submits BLA For VIASKIN Peanut Patch In Children With Peanut Allergy",
  "url": "https://urgent.news/2026/09/30/dbv-submits-bla-for-viaskin-peanut-patch-in-children-with-peanut",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-30T03:24:40.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/dbv-submits-bla-viaskin-peanut-patch-children-peanut-allergy"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - DBV Technologies (DBVT) announced the submission of a Biologics License Application to the U.S. FDA for the VIASKIN Peanut Patch in children aged 4 to 7 years with peanut allergy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}